News Archives - Muscular Dystrophy News
WEBA noninvasive quantitative MRI, or qMRI, was found to detect early muscle abnormalities among people with limb-girdle muscular dystrophy type R1 (LGMDR1), according to a small study from Europe. Many of the qMRI findings correlated with clinical assessments of muscle function and patient-reported activities. “Our findings revealed alterations ...
Muscular Dystrophy News Home | Muscular Dystrophy News
WEB6 days ago — DMD treatment WVE-N531 boosts dystrophin: Interim trial data. Treatment with exon 53-skipping therapy WVE-N531 led to significant increases in muscle dystrophin levels along with signs of improved muscle health and regeneration in boys with Duchenne muscular dystrophy (DMD). That’s according to new …
Ataluren for Duchenne muscular dystrophy
WEBMay 22, 2024 — Ataluren is an oral small molecule designed to preserve walking and muscle function in people with Duchenne muscular dystrophy (DMD) caused by so-called nonsense mutations. The therapy, developed by PTC Therapeutics, was conditionally approved in the European Union (EU) in 2014, under the band name Translarna, and …
FDA approves oral givinostat, as Duvyzat, to treat Duchenne MD
WEBMar 22, 2024 — Therapy is 1st non-steroidal drug for patients with all genetic DMD variants. The U.S. Food and Drug Administration (FDA) has approved Italfarmaco’s givinostat, which will now be marketed as Duvyzat, as an oral suspension to treat people with Duchenne muscular dystrophy (DMD) ages 6 and older. Duvyzat becomes the …
FDA gives WVE-N531, exon 53 skipping therapy, supportive status
WEBAug 20, 2024 — The U.S. Food and Drug Administration (FDA) has given WVE-N531, an investigational therapy for Duchenne muscular dystrophy (DMD) patients amenable to exon 53 skipping, a rare pediatric drug designation. This status aims to incentivize companies developing treatments for serious or life-threatening …
MD and Your Heart Monitor: 6 Things I Wish I'd Known
WEBJan 23, 2018 — 1. Use lotion to remove adhesive. Lotion is the easiest way to remove the adhesive on your skin left from the stickers that connect to the electrodes. It is also the least irritating for your skin, especially if you have sensitive skin like me. Let the lotion sink into your skin before wiping of the adhesive with some tissue paper.
News – Muscular Dystrophy News
WEBDisclaimer. This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
Amondys 45 (Casimersen) - Muscular Dystrophy News
WEBOct 18, 2023 — Amondys 45 (casimersen) is an approved exon-skipping therapy for Duchenne muscular dystrophy (DMD) patients with mutations amenable to exon 45 skipping. The treatment is infused into the vein, or intravenously, and is Sarepta Therapeutics ’ third exon-skipping therapy to be approved by the U.S. Food and Drug Administration (FDA) for DMD ...
Duchenne muscular dystrophy: Exercise and physical therapy
WEBJun 17, 2024 — Physical therapy is an important part of a Duchenne muscular dystrophy (DMD) treatment plan. It helps maintain flexibility, range of motion, and muscle strength, while also addressing changes in mobility. A physical therapist knowledgeable about DMD and progressive muscle weakness and other DMD symptoms can create a therapeutic exercise program ...
What Is Facioscapulohumeral Muscular Dystrophy (FSHD)?
WEBJan 20, 2022 — Facioscapulohumeral muscular dystrophy — sometimes abbreviated as FMD, FSH, or FSHD — is a form of muscular dystrophy that affects roughly one out of every 8,000 people, or about 870,000 people worldwide.. The disease gets its name because it characteristically affects muscles of the face (“facio”), the shoulders (“scapulo,” referring to the shoulder blade or scapula), and upper ...